Bellevue Group’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-855,293
| Closed | -$23.1M | – | 178 |
|
|
2024
Q2 | $23.1M | Sell |
855,293
-662,937
| -44% | -$13.8M | 0.38% | 66 |
|
|
2024
Q1 | $27.8M | Buy |
1,518,230
+82,548
| +6% | +$1.31M | 0.42% | 68 |
|
|
2023
Q4 | $17.6M | Buy |
1,435,682
+5,120
| +0.4% | +$48K | 0.27% | 79 |
|
|
2023
Q3 | $21.4M | Buy |
1,430,562
+73,799
| +5% | +$1.54M | 0.35% | 72 |
|
|
2023
Q2 | $44.1M | Buy |
1,356,763
+287,024
| +27% | +$10.5M | 0.63% | 54 |
|
|
2023
Q1 | $41.9M | Buy |
1,069,739
+57,216
| +6% | +$2.8M | 0.61% | 52 |
|
|
2022
Q4 | $53.5M | Sell |
1,012,523
-34,833
| -3% | -$1.7M | 0.71% | 44 |
|
|
2022
Q3 | $47.1M | Buy |
1,047,356
+70
| +0% | +$3.01K | 0.68% | 46 |
|
|
2022
Q2 | $38.1M | Buy |
1,047,286
+1,719
| +0.2% | +$62.5K | 0.54% | 56 |
|
|
2022
Q1 | $43.2M | Buy |
1,045,567
+93,134
| +10% | +$3.28M | 0.5% | 63 |
|
|
2021
Q4 | $40.6M | Buy |
952,433
+170,773
| +22% | +$8.54M | 0.42% | 73 |
|
|
2021
Q3 | $43M | Sell |
781,660
-512,099
| -40% | -$26.8M | 0.44% | 71 |
|
|
2021
Q2 | $61.9M | Buy |
1,293,759
+134,835
| +12% | +$6.87M | 0.6% | 55 |
|
|
2021
Q1 | $58.7M | Buy |
1,158,924
+786,034
| +211% | +$43.7M | 0.62% | 53 |
|
|
2020
Q4 | $23.5M | Buy |
372,890
+72,271
| +24% | +$4.48M | 0.27% | 92 |
|
|
2020
Q3 | $20.2M | Buy |
300,619
+55,281
| +23% | +$3.02M | 0.28% | 89 |
|
|
2020
Q2 | $10.3M | Buy |
245,338
+50,755
| +26% | +$1.95M | 0.15% | 106 |
|
|
2020
Q1 | $6.13M | Buy |
194,583
+10,687
| +6% | +$428K | 0.12% | 109 |
|
|
2019
Q4 | $7.43M | Buy |
183,896
+51,942
| +39% | +$1.82M | 0.12% | 104 |
|
|
2019
Q3 | $4.29M | Buy |
131,954
+5,144
| +4% | +$205K | 0.08% | 114 |
|
|
2019
Q2 | $6.14M | Buy |
+126,810
| New | +$5.39M | 0.1% | 104 |
|
Other funds holding SILK
Bellevue Group's SILK Position: Q3 2024 in Review
Bellevue Group sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 855,293 shares — an estimated $23.1M sold.
Bellevue Group first reported a position in SILK in Q2 2019 and held it in 21 quarters. The position peaked at $61.9M in Q2 2021. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Bellevue Group reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Bellevue Group sold 855,293 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $23.1M.
- Bellevue Group first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 21 quarters.
- Bellevue Group's Silk Road Medical, Inc. Common Stock position peaked at $61.9M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Bellevue Group's 13F filing for Q3 2024, filed 14 Nov 2024.